OTCMKTS:ASNB EKIMAS (ASNB) Stock Price, News & Analysis $1.90 -0.25 (-11.63%) As of 08/29/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsBuy This Stock About EKIMAS Stock (OTCMKTS:ASNB) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get EKIMAS alerts:Sign Up Key Stats Today's Range$1.90▼$1.9050-Day Range$1.80▼$4.0052-Week Range$0.55▼$1.75Volume1,000 shsAverage Volume3,162 shsMarket Capitalization$11.02 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview EKIMAS Corp. engages in the development of polymer materials, which provide characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. The firm's products include ChronoFlex, ChronoSil, HydroMed, HydroThane, and PolyBlend. The company was founded in 1993 and is headquartered in Las Vegas, NV. Read More Receive ASNB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EKIMAS and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ASNB Stock News HeadlinesEKIMAS CORPORATION COMPLETES THE EXERCISE OF WARRANTSMarch 8, 2023 | finance.yahoo.comNORDICUS PARTNERS A/S COMPLETES REVERSE ACQUISITION TRANSACTION WITH EKIMAS CORPORTIONMarch 1, 2023 | finance.yahoo.comRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns just aren’t enough anymore. But what if you could reach your Freedom Number—the monthly income that makes retirement secure—using far less money than you thought possible? That’s exactly what Kelly G. discovered. She calls it “life-changing,” saying the income just keeps growing and that early retirement suddenly looks real. This strategy was once reserved for the ultra-wealthy, but it’s now available to everyday investors.September 1 at 2:00 AM | Investors Alley (Ad)ASNB.PK - Ekimas Corp | Stock Price & Latest News | ReutersSeptember 14, 2022 | reuters.comUpdated EKIMAS Corporation Announces Special Cash DistributionSeptember 12, 2022 | finance.yahoo.comWhat does ‘WYLL’ mean on TikTok and Snapchat?September 10, 2022 | yahoo.comEKIMAS Corporation (ASNB)August 28, 2022 | finance.yahoo.comSee More Headlines ASNB Stock Analysis - Frequently Asked Questions How have ASNB shares performed this year? EKIMAS's stock was trading at $9.00 on January 1st, 2025. Since then, ASNB shares have decreased by 78.9% and is now trading at $1.90. How were EKIMAS's earnings last quarter? EKIMAS Co. (OTCMKTS:ASNB) issued its earnings results on Thursday, October, 16th. The company reported $0.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.29 by $0.02. How do I buy shares of EKIMAS? Shares of ASNB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of EKIMAS own? Based on aggregate information from My MarketBeat watchlists, some other companies that EKIMAS investors own include Associated Banc (ASB), MediWound (MDWD), PermRock Royalty Trust (PRT), Meta Platforms (META), Adobe (ADBE), Actinium Pharmaceuticals (ATNM) and CytoDyn (CYDY). Company Calendar Last Earnings10/16/2014Today9/01/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Surgical & medical instruments Sub-IndustryBusiness Services Current SymbolOTCMKTS:ASNB Previous SymbolAMEX:ASB CIK1011060 Webwww.advbiomaterials.com Phone(424) 256-8560Fax978-657-0074Employees11Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$290 thousand Net MarginsN/A Pretax MarginN/A Return on Equity-7,902.31% Return on Assets-5,274.01% Debt Debt-to-Equity RatioN/A Current Ratio0.12 Quick Ratio0.12 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.03 per share Price / Book63.33Miscellaneous Outstanding Shares5,799,000Free Float5,347,000Market Cap$11.02 million OptionableNot Optionable Beta0.37 Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (OTCMKTS:ASNB) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredA Major Economic Change Is Happening NowLouis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and ea...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EKIMAS Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share EKIMAS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ASNB Stock Alerts